Clinical outcome and cosmesis in African-American patients treated with conservative surgery and radiation therapy

Cancer Journal

Volumn 9, Issue 4, 2003, Pages 313-320

  Tuamokumo, Nimi L ^a   Haffty, Bruce G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

African American; Breast conserving surgery; Cosmesis; Race; Radiation therapy

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; BREAST FIBROSIS; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SIZE; CANCER SURVIVAL; CAUCASIAN; CLINICAL FEATURE; CONTROLLED STUDY; EDEMA; ESTHETICS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; ONSET AGE; PARTIAL MASTECTOMY; PIGMENTATION; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; TREATMENT OUTCOME; ADJUVANT THERAPY; BREAST TUMOR; CASE CONTROL STUDY; COMPARATIVE STUDY; FIBROSIS; SEGMENTAL MASTECTOMY; SKIN PIGMENTATION; STATISTICS; SURVIVAL;

AFRICAN AMERICANS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EDEMA; ESTHETICS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FIBROSIS; HUMANS; MASTECTOMY, SEGMENTAL; RADIOTHERAPY, ADJUVANT; SKIN PIGMENTATION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0642276505     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200307000-00014     Document Type: Article

References (41)

1. Greenlee RT, Murray T, Bolden S et al. Cancer statistics, 2000. CA Cancer J Clin 2000;50:7-33.
2. Hunter CP, Redmond CK, Chen VW et al. Breast cancer: factors associated with stage at diagnosis in black and white women. Black/White Cancer Survival Study Group. J Natl Cancer Inst 1993;85:1129-1137.
3. Baquet CR, Commiskey P. Socioeconomic factors and breast carcinoma in multicultural women. Cancer 2000;88:1256-1264.
4. Burns RB, McCarthy EP, Freund KM et al. Black women receive less mammography even with similar use of primary care. Ann Intern Med 1996;125:173-182.
5. National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000. J Natl Cancer Inst Monogr 2001;30:5-15.
6. Blichert-Toft M, Rose C, Andersen JA et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr 1992;11:19-25.
7. Fisher B, Anderson S, Redmond CK et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer.NEngl J Med 1995;333:1456-1461.
8. Haffty BG, Ward BA. Is breast-conserving surgery with radiation superior to mastectomy in selected patients? Cancer J Sci Am 1997;3:2-3.
9. van Dongen JA, Voogd AC, Fentiman IS et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000;92:1143-1150.
10. Veronesi U, Marubini E, Mariani L et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 2001;12:997-1003.
11. Veronesi U, Zucali R, Del Vecchio M. Conservative treatment of breast cancer with QU. A. R. T. Technique. World J Surg 1985;9:676-681.
12. Margolis G, Goodman RL, Rubin A. Psychological effects of breast-conserving cancer treatment and mastectomy. Psychosomatics 1990;31:33-39.
13. Margolis GJ, Goodman RL. Psychological effects of breast conservation versus mastectomy. J Clin Oncol 1989;7:1365-1366.
14. Pierce L, Fowble B, Solin LJ et al. Conservative surgery and radiation therapy in black women with early stage breast cancer: patterns of failure and analysis of outcome. Cancer 1992;69:2831-2841.
15. Joslyn SA, West MM. Racial differences in breast carcinoma survival. Cancer 2000;88:114-123.
16. Prodas Reference Manual, Version 3.0. Houston, PRODAS, 1985.
17. de la Rochefordiere A, Asselain B, Campana F et al. Age as prognostic factor in premenopausal breast carcinoma. Lancet 1993;341:1039-1043.
18. Fourquet A, Campana F, Zafrani B et al. Prognostic factors of breast recurrence in the conservativemanagement of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys 1989;17:719-725.
19. Fowble BL, Schultz DJ, Overmoyer B et al. The influence of young age on outcome in early stage breast cancer. Int J Radiat Oncol Biol Phys 1994;30:23-33.
20. Harrold EV, Turner BC, Matloff ET et al. Local recurrence in the conservatively treated breast cancer patient: a correlation with age and family history. Cancer J Sci Am 1998;4:302-307.
21. Veronesi U, Marubini E, Del Vecchio M et al. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst 1995;87:19-27.
22. Lyman GH, Kuderer NM, Lyman SL et al. Importance of race on breast cancer survival. Ann Surg Oncol 1997;4:80-87.
23. Connor CS, Touijer AK, Krishnan L et al. Local recurrence following breast conservation therapy in African-American women with invasive breast cancer. Am J Surg 2000;179:22-26.
24. Bartelink H, Horiot JC, Poortmans P et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001;345:1378-1387.
25. Haffty BG, Fischer D, Rose M et al. Prognostic factors for local recurrence in the conservatively treated breast cancer patient: a cautious interpretation of the data. J Clin Oncol 1991;9:997-1003.
26. Vicini FA, Kestin LL, Goldstein NS et al. Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breast-conserving therapy. J Clin Oncol 2000;18:296-306.
27. Gao Q, Tomlinson G, Das S et al. Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer. Hum Genet 2000;107:186-191.
28. Newman B, Mu H, Butler LM et al. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA 1998;279:915-921.
29. Shen D, Wu Y, Subbarao M et al. Mutation analysis of BRCA1 gene in African-American patients with breast cancer. J Natl Med Assoc 2000;92:29-35.
30. Blaszyk H, Vaughn CB, Hartmann A et al. Novel pattern of p53 gene mutations in an American black cohort with high mortality from breast cancer. Lancet 1994;343:1195-1197.
31. Krieger N, van den Eeden SK, Zava D et al. Race/ethnicity, social class, and prevalence of breast cancer prognostic biomarkers: a study of white, black, and Asian women in the San Francisco bay area. Ethn Dis 1997;7:137-149.
32. Ameyaw MM, Tayeb M, Thornton N et al. Ethnic variation in the HER-2 codon 655 genetic polymorphism previously associated with breast cancer. J Hum Genet 2002;47:172-175.
33. Taylor ME, Perez CA, Halverson KJ et al. Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys 1995;31:753-764.
34. Pierce SM, Recht A, Lingos TI et al. Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys 1992;23:915-923.
35. Rose MA, Olivotto I, Cady B et al. Conservative surgery and radiation therapy for early breast cancer: long-term cosmetic results. Arch Surg 1989;124:153-157.
36. Olivotto IA, Rose MA, Osteen RT et al. Late cosmetic outcome after conservative surgery and radiotherapy: analysis of causes of cosmetic failure. Int J Radiat Oncol Biol Phys 1989;17:747-753.
37. Recht A, Hayes DF, Harris JR. The use of adjuvant therapy in patients treated with conservative surgery and radiotherapy. Cancer Treat Res 1992;60:223-237.
38. Morrow M, Jordan VC, Takei H et al. Current controversies in breast cancer management. Curr Probl Surg 1999;36:163-216.
39. Lee TY, Chin GS, Kim WJ et al. Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids. Ann Plast Surg 1999;43:179-184.
40. Chin GS, Liu W, Peled Z et al. Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts. Plast Reconstr Surg 2001;108:423-429.
41. Iannuzzi CM, Atencio DP, Green S et al. ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects. Int J Radiat Oncol Biol Phys 2002;52:606-613.